Ajjai Alva
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 66
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 41
-
- Renal cell carcinoma treatment 54
- Prostate Cancer Treatment and Research 49
- Health Informatics top 5%
-
- Radiopharmaceutical Chemistry and Applications 22
-
- Bladder and Urothelial Cancer Treatments 96
- Urinary and Genital Oncology Studies 40
-
- Renal and related cancers 19
- Co-authors
- Helen C. SuMichael J. LenardoSarah J. WelshParmesh DuttEric C. FreundtLi YuEric H. BaehreckeAlon Z. Weizer
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ajjai Alva
202 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 2.0k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 2.3k
- Health Informatics 45
- Radiology, Nuclear Medicine and Imaging 683
Countries citing papers authored by Ajjai Alva
This map shows the geographic impact of Ajjai Alva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajjai Alva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajjai Alva more than expected).
Fields of papers citing papers by Ajjai Alva
This network shows the impact of papers produced by Ajjai Alva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajjai Alva. The network helps show where Ajjai Alva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ajjai Alva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 12 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 28 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 0 | |
| 13 | 2021 | 58 | |
| 14 | 2021 | 33 | |
| 15 | 2021 | 15 | |
| 16 | 2021 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 63 | |
| 19 | 2015 | 86 | |
| 20 | Regulation of an ATG7 - beclin 1 Program of Autophagic Cell Death by Caspase-8breakdown → | 2004 | 1023 |
About Ajjai Alva
Ajjai Alva is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 218 papers that have together received 5.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (96 papers), Cancer Immunotherapy and Biomarkers (66 papers), Renal cell carcinoma treatment (54 papers), Prostate Cancer Treatment and Research (49 papers), Cancer Genomics and Diagnostics (41 papers), Urinary and Genital Oncology Studies (40 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Renal and related cancers (19 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (1.1k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Ajjai Alva has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Helen C. Su, Michael J. Lenardo, Sarah J. Welsh, Parmesh Dutt, Eric C. Freundt, Li Yu, Eric H. Baehrecke, Alon Z. Weizer, Maha Hussain and Arul M. Chinnaiyan. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.